SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

13 Aug 2024 Evaluate
The sales figure stood at Rs. 1034.10 millions for the June 2024 quarter. The mentioned figure indicates a growth of about 48.68% as compared to Rs. 695.50 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -34.70 millions as compared to Net Loss of Rs. -213.30 millions of corresponding quarter ended June 2023The company reported a good operating profit of 264.90 millions compared to 94.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1034.10 695.50 48.68 1034.10 695.50 48.68 3273.50 4025.50 -18.68
Other Income 115.90 144.40 -19.74 115.90 144.40 -19.74 630.50 521.60 20.88
PBIDT 264.90 94.20 181.21 264.90 94.20 181.21 698.50 599.20 16.57
Interest 157.30 177.60 -11.43 157.30 177.60 -11.43 681.90 579.20 17.73
PBDT 107.60 -83.40 -229.02 107.60 -83.40 -229.02 -13.90 0.00 0.00
Depreciation 163.20 246.90 -33.90 163.20 246.90 -33.90 1016.10 962.00 5.62
PBT -55.60 -330.30 -83.17 -55.60 -330.30 -83.17 -1030.00 -962.00 7.07
TAX -20.90 -117.00 -82.14 -20.90 -117.00 -82.14 -265.90 -373.30 -28.77
Deferred Tax -20.90 -117.00 -82.14 -20.90 -117.00 -82.14 -376.50 -373.30 0.86
PAT -34.70 -213.30 -83.73 -34.70 -213.30 -83.73 -764.10 -588.70 29.79
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 25.62 13.54 89.13 25.62 13.54 89.13 21.34 14.89 43.35

Dishman Carbogen Amc Share Price

170.80 0.30 (0.18%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: